Effect of tyrosine kinase inhibitors on male fertility in patients with chronic phase chronic myeloid leukemia

被引:5
作者
Nesr, George [1 ]
Claudiani, Simone [1 ]
Milojkovic, Dragana [2 ]
Innes, Andrew [1 ]
Fernando, Fiona [2 ]
Caballes, Irene [2 ]
Mungozi, Patience [2 ]
Szydlo, Richard [1 ]
Lovato, Silvia [1 ]
Jayasena, Channa [3 ,4 ]
Apperley, Jane [1 ]
机构
[1] Imperial Coll London, Ctr Haematol, London, England
[2] Imperial Coll Healthcare NHS Trust, Dept Clin Haematol, London, England
[3] Imperial Coll London, Fac Med, Sect Invest Med, London, England
[4] Hammersmith Hosp, Dept Androl, North West London Pathol, London, England
关键词
Chronic myeloid leukemia; tyrosine kinase inhibitors; fertility; semen analysis; IMATINIB MESYLATE; PREGNANCIES; IMPACT;
D O I
10.1080/10428194.2024.2343758
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Advancements in the management of patients with chronic myeloid leukemia (CML) allowed them to achieve survival comparable with their healthy counterparts. Consequently, their care has widened with growing focus on quality of life, including parenting children. Although tyrosine kinase inhibitors (TKI) are contraindicated in pregnancy given their teratogenic effect, their effect on male fertility is less clear with contradictory results from animal studies and case reports/series. We compared the sperm analysis parameters, as the gold-standard assessment for male fertility, of 11 patients with CP- CML before and after TKI therapy. Median therapy duration was 5.1 years (range: 2.5-16.5). The sperm concentration, % progressive, and total motility before and after therapy were not significantly different (p = 0.376, 0.569, and 0.595, respectively). Our results suggest no impairment in fertility potential in male patients after TKI therapy. A larger sample size is crucial to support/refute our findings.
引用
收藏
页码:1161 / 1166
页数:6
相关论文
共 36 条
[1]   Management of pregnant chronic myeloidleukemia patients [J].
Abruzzese, Elisabetta ;
Trawinska, Malgorzata Monika ;
de Fabritiis, Paolo ;
Baccarani, Michele .
EXPERT REVIEW OF HEMATOLOGY, 2016, 9 (08) :781-791
[2]   Imatinib mesylate effects on zebrafish reproductive success: Gonadal development, gamete quality, fertility, embryo-larvae viability and development, and related genes [J].
Ahmadi, Nader ;
Samaee, Seyed-Mohammadreza ;
Yokel, Robert A. ;
Tehrani, Aliasghar .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2019, 379
[3]  
[Anonymous], NCCN clinical practice guidelines in oncology: Bone Cancer
[4]  
[Anonymous], WHO Laboratory Manual for the Examination of Human Semen and Sperm-Cervical Mucus Interaction, Vrd
[5]   Pregnancy among patients with chronic myeloid leukemia treated with imatinib [J].
Ault, P ;
Kantarjian, H ;
O'Brien, S ;
Faderl, S ;
Beran, M ;
Rios, MB ;
Koller, C ;
Giles, F ;
Keating, M ;
Talpaz, M ;
Cortes, J .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (07) :1204-1208
[6]   Male patients with chronic myeloid leukemia treated with imatinib involved in healthy pregnancies: Report of five cases [J].
Breccia, Massimo ;
Cannella, Laura ;
Montefusco, Enrico ;
Frustaci, Annamaria ;
Pacilli, Matteo ;
Alimena, Giuliana .
LEUKEMIA RESEARCH, 2008, 32 (03) :519-520
[7]   Pregnancy outcome among partners of male patients receiving imatinib, dasatinib or nilotinib in chronic myeloid leukemia: reports collected by the French network pharmacovigilance centers [J].
Carlier, Patrick ;
Bernard, Nathalie ;
Lagarce, Laurence ;
Dautriche, Anne ;
Bene, Johana ;
Sam-Lai, Nathalie Fouilhe ;
Eftekhari, Pirayeh .
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2017, 295 (02) :269-271
[8]   Impact of Imatinib on the Fertility of Male Patients with Chronic Myelogenous Leukaemia in the Chronic Phase [J].
Chang, Xiaohui ;
Zhou, Lin ;
Chen, Xiaoxia ;
Xu, Baoli ;
Cheng, Yubin ;
Sun, Shujun ;
Fang, Meiyun ;
Xiang, Yang .
TARGETED ONCOLOGY, 2017, 12 (06) :827-832
[9]  
Cortes Jorge E, 2020, Int J Hematol Oncol, V9, pIJH26, DOI 10.2217/ijh-2020-0004
[10]  
FDA, 2023, DASATINIB PACKAGE IN